Total (n = 630) | Survivors (n = 451) | Non-survivors (n = 179) | |
---|---|---|---|
Guideline concordant group | 359 | 274 (60.8) | 85 (47.5) |
Antipseudomonal β-lactam + fluoroquinolone | 169 (47.1) | 120 (43.8) | 49 (57.6) |
Non-antipseudomonal β-lactam + azithromycin | 108 (30.1) | 92 (33.6) | 16 (18.8) |
Non-antipseudomonal β-lactam + fluoroquinolone | 82 (22.8) | 62 (22.6) | 20 (23.5) |
Guideline discordant group | 271 | 177 (39.3) | 94 (52.5) |
β-lactam | 158 (58.3) | 96 (54.2) | 62 (66.0) |
β-lactam + anti-anaerobes | 84 (31.0) | 56 (31.6) | 28 (29.8) |
β-lactam + vancomycin | 1 (0.3) | 1 (0.6) | 0 (0.0) |
Fluoroquinolone | 19 (7.0) | 16 (9.0) | 3 (3.2) |
Carbapenem | 9 (3.3) | 8 (4.5) | 1 (1.0) |